Curative Biotechnology's total assets for Q2 2026 were $2.16M, an increase of 4.27% from the previous quarter. CUBT total liabilities were $8.55M for the fiscal quarter, a 2.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.